Administration of ADAKVEO® follows a 5 mg/kg by intravenous infusion over a period of 30 minutes on Week 0, Week 2, and every 4 weeks thereafter.
Most common adverse reactions (incidence > 10%) are nausea, arthralgia, back pain, abdominal pain, and pyrexia.
Please see full Prescribing Information including Patient Information.
|
6501 Broadway Extension
Suite 100
Oklahoma City, OK, 73116
P / 405-832-3510
F / 405-832-3515
Email: vcoklahomacity@vitalcare.com
Privacy Policy | © 2024 Vital Care of Oklahoma